Cytori Therapeutics Inc Warrant
CYTXW
CYTXW was delisted on the 14th of December, 2018.
5 hedge funds and large institutions have $46K invested in Cytori Therapeutics Inc Warrant in 2017 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 0 closing their positions.
67% more funds holding
Funds holding: 3 → 5 (+2)
90% less capital invested
Capital invested by funds: $461K → $46K (-$415K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$1.02K |
| 2 |
MCM
Manchester Capital Management
Manchester,
Vermont
|
+$1 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$2.37K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$56 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $45K | -$2.37K | -24,500 | -2% |
|
2
Creative Planning
Overland Park,
Kansas
| $1K | – | – | – |
|
|
3
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$56 | -583 | -92% |
|
|
MCM
4
Manchester Capital Management
Manchester,
Vermont
| – | +$1 | +7 | New |
|
|
VF
5
Virtu Financial
New York
| – | +$1.02K | +10,504 | New |
|
CYTXW Hedge Fund Activity: Q3 2017 in Review
5 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Cytori Therapeutics Inc Warrant (CYTXW) for Q3 2017, worth a combined $46K — down 90% from $461K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new CYTXW positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 2 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $1.02K. The largest seller was Sabby Management, cutting an estimated $2.37K.
- 5 institutional investors held Cytori Therapeutics Inc Warrant (CYTXW) as of Q3 2017, up from 3 in Q2 2017.
- Funds reported $46K of Cytori Therapeutics Inc Warrant stock for Q3 2017, down 90% quarter-over-quarter.
- 2 funds opened new Cytori Therapeutics Inc Warrant positions in Q3 2017 and 0 closed out, a net change of +2 holders.
- The largest Cytori Therapeutics Inc Warrant buyer in Q3 2017 was Virtu Financial, an estimated $1.02K added.
- The largest Cytori Therapeutics Inc Warrant seller in Q3 2017 was Sabby Management, an estimated $2.37K sold.
Based on aggregated 13F filings for Q3 2017.